Featured Research

from universities, journals, and other organizations

UCSF Reports Promising Results For Organ Transplantation In HIV-Infected Patients

Date:
February 28, 2002
Source:
University Of California - San Francisco
Summary:
Early findings from a multi-site study led by UCSF investigators show that 95% of the HIV-infected patients in the study who received kidney transplants and 84% who received liver transplants in this era of Highly Active Anti-Retroviral Therapy (HAART), are surviving nearly one year post-transplant—rates comparable to non-HIV-infected kidney and liver transplant recipients for the same period.

Seattle -- Early findings from a multi-site study led by UCSF investigators show that 95% of the HIV-infected patients in the study who received kidney transplants and 84% who received liver transplants in this era of Highly Active Anti-Retroviral Therapy (HAART), are surviving nearly one year post-transplant—rates comparable to non-HIV-infected kidney and liver transplant recipients for the same period.

The study, which looked at 41 HIV-infected patients who have received liver and kidney transplants, also showed comparable rates for grafted organ function with 89% of the kidney grafts and 84% of the liver grafts functioning nearly one year post-transplant in the HIV-infected recipients. The findings, collected retrospectively from UCSF and collaborating transplant centers around the country, were presented at the 9th Conference on Retroviruses and Opportunistic Infections.

“HIV disease does not seem to be progressing at an appreciable rate post-transplant in eligible subjects—those without a history of opportunistic infections, with relatively preserved CD4 T-cell counts, and suppressed or suppressible HIV virus,” said the study’s lead investigator, Michelle E. Roland, MD, UCSF assistant professor of medicine in the Positive Health Program at San Francisco General Hospital Medical Center.

“With the caveats that this data is retrospective—a prospective study is in process—and very preliminary, we can say that the news so far is extremely good for those subjects who met the eligible subject criteria,” said study co-investigator, Peter G. Stock, MD, UCSF associate professor of surgery.

“In addition, we noted data on 8 HIV-infected subjects who received transplants—6 kidney, 2 liver—but who did not meet the study eligibility criteria and were not part of the 41 included in the study. Two—one liver recipient, one kidney recipient—of those patients died,” said Roland.

Of the 19 study-eligible patients who received liver transplants, 16 have survived. Twenty-one of the 22 study-eligible patients who received kidneys have survived. The comparable rates for non-HIV-infected patients from the United Network for Organ Sharing (UNOS)—the government-funded clearinghouse that keeps the waiting lists governing who gets organs—were 87.9% survival rates for liver recipients, 94.8% for recipients of kidneys from cadavers and 97.6% for recipients of kidneys from a living donor.

Co-investigators include Laurie L. Carlson, RN, transplant study coordinator, UCSF’s division of transplant surgery; Margaret Ragni, M.D., M.P.H., professor of medicine, University of Pittsburgh, director of the Hemophilia Center of Western Pennsylvania; Susie R. Rohal, RN, BSN, CCTC, clinical research coordinator, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center; Marla Keller, MD, HIV specialist at the AIDS Center, Jeffrey Jacobson, MD, director of the AIDS Center, and Leona Kim-Schluger, MD, hepatologist, Mount Sinai Medical Center; Barbara Murphey, MD, assistant professor of medicine in the renal division, Mount Sinai School of Medicine; Abhinav Humar, MD, assistant professor of surgery, University of Minnesota; Timothy Pruett, MD, chief of transplantation, and Carl Berg, MD, hepatologist, University of Virginia; Amy Lu, MD, assistant professor of surgery, Georgetown University; William D. Bennett, MD, medical director of the transplant center, Maggie Allee, RN, director of Legacy Organ Transplant Services, Legacy Good Samaritan Hospital, Portland, Oregon; Kim Olthoff, MD, program director of liver transplantation, Children’s Hospital of Philadelphia, assistant professor of surgery, University of Pennsylvania; Anil Mysore Kumar, MD, MBBS, professor of medicine, Marla J.Gold, MD, associate professor of medicine, Anna Damask, RN, transplant study coordinator, MCP Hahnemann University; Jimmy A. Light, MD, director of the Transplant Research Center, Washington Hospital Center, Washington D.C.; Robert Redfield, MD, professor of medicine, associate director of the Institute of Human Virology, University of Maryland; Christopher B.Hughes, MD, transplant surgeon, Mayo Clinic, Jacksonville, Florida; David Simon, MD, associate professor of internal medicine, Rush University.

This study was supported by grants from the University-Wide AIDS Research Program of the State of California and the National Institutes for Health.


Story Source:

The above story is based on materials provided by University Of California - San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University Of California - San Francisco. "UCSF Reports Promising Results For Organ Transplantation In HIV-Infected Patients." ScienceDaily. ScienceDaily, 28 February 2002. <www.sciencedaily.com/releases/2002/02/020228072359.htm>.
University Of California - San Francisco. (2002, February 28). UCSF Reports Promising Results For Organ Transplantation In HIV-Infected Patients. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2002/02/020228072359.htm
University Of California - San Francisco. "UCSF Reports Promising Results For Organ Transplantation In HIV-Infected Patients." ScienceDaily. www.sciencedaily.com/releases/2002/02/020228072359.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

AFP (Sep. 16, 2014) Since the arrival of Ebola in Ivory Coast, Ivorians have been abandoning their pets, particularly monkeys, in the fear that they may transmit the virus. Duration: 00:47 Video provided by AFP
Powered by NewsLook.com
Study Links Male-Pattern Baldness To Prostate Cancer

Study Links Male-Pattern Baldness To Prostate Cancer

Newsy (Sep. 16, 2014) New findings suggest men with a certain type of baldness at age 45 are 39 percent more likely to develop aggressive prostate cancer. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins